Patent · US Active

siRNA targeting gremlin

US7569684B2 · kind B2 · utility

55Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 30, 2007
Grant dateAug 4, 2009
Priority date
Expiry dateMar 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/11
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to CKSF1B1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.